PubMed:26546614 / 1277-1378
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T91 | 33-38 | PR:Q5S006 | denotes | LRRK2 |
T92 | 33-38 | PR:000003033 | denotes | LRRK2 |
T93 | 33-38 | PR:Q5S007 | denotes | LRRK2 |
T94 | 39-54 | GO:0016301 | denotes | kinase activity |
T95 | 71-78 | SO:0100018 | denotes | binding |
T96 | 71-78 | SO:0001091 | denotes | binding |
T97 | 71-78 | GO:0005488 | denotes | binding |
T98 | 95-100 | PR:Q5S006 | denotes | LRRK2 |
T99 | 95-100 | PR:000003033 | denotes | LRRK2 |
T100 | 95-100 | PR:Q5S007 | denotes | LRRK2 |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 0-101 | DRI_Challenge | denotes | The ability of 14-3-3θ to reduce LRRK2 kinase activity required direct binding of 14-3-3θ with LRRK2. |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-101 | DRI_Challenge | denotes | The ability of 14-3-3θ to reduce LRRK2 kinase activity required direct binding of 14-3-3θ with LRRK2. |